Does SAQUINAVIR Cause Lipodystrophy acquired? 186 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 186 reports of Lipodystrophy acquired have been filed in association with SAQUINAVIR. This represents 23.5% of all adverse event reports for SAQUINAVIR.
186
Reports of Lipodystrophy acquired with SAQUINAVIR
23.5%
of all SAQUINAVIR reports
0
Deaths
0
Hospitalizations
How Dangerous Is Lipodystrophy acquired From SAQUINAVIR?
Of the 186 reports.
Is Lipodystrophy acquired Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SAQUINAVIR. However, 186 reports have been filed with the FAERS database.
What Other Side Effects Does SAQUINAVIR Cause?
Eyelid ptosis (169)
Mitochondrial toxicity (165)
Diplopia (161)
Foetal exposure during pregnancy (105)
Dysphagia (103)
Viral mutation identified (82)
Drug resistance (77)
Progressive external ophthalmoplegia (74)
Pathogen resistance (67)
Ophthalmoplegia (66)
What Other Drugs Cause Lipodystrophy acquired?
LAMIVUDINE (383)
ZIDOVUDINE (313)
NEVIRAPINE (288)
STAVUDINE (283)
RITONAVIR (254)
LOPINAVIR\RITONAVIR (230)
DIDANOSINE (216)
TENOFOVIR DISOPROXIL (205)
EFAVIRENZ (203)
INDINAVIR (195)
Which SAQUINAVIR Alternatives Have Lower Lipodystrophy acquired Risk?
SAQUINAVIR vs SARECYCLINE
SAQUINAVIR vs SARGRAMOSTIM
SAQUINAVIR vs SARILUMAB
SAQUINAVIR vs SATRALIZUMAB
SAQUINAVIR vs SATRALIZUMAB-MWGE